Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Unique Handheld Diagnostic Device - First of its Type in the Marketplace

Published: Monday, March 18, 2013
Last Updated: Sunday, March 17, 2013
Bookmark and Share
AgPlus Diagnostics unveils the first working prototype of their unique new handheld system for rapid, on-the-spot diagnostic results.

AgPlus Diagnostics has announced that the first functional prototype of the handheld AgPlus Diagnostics analytical platform is now fully operational and available for demonstration.

Delivering laboratory-grade, quantifiable results within just 10 minutes of sample application the portable AgPlus technology system has enormous potential in a wide variety of applications where a rapid, accurate and sensitive result is important for fast and reliable decision making.

The AgPlus Diagnostics platform utilizes electrochemical immunoassay technology in a patented microfluidic chip format.

The unique signalling and measurement system, based on the detection of amplified silver ions by anodic stripping voltammetry, allows extremely sensitive, accurate and quantifiable results to be obtained from a very small sample volume (50µl) within minutes.

The system does not rely on an optical based detection method, so no sample preparation is required, making it ideal for multiple sample types and for testing in a range of settings.

The first fully functional AgPlus technology prototype will demonstrate an assay for human Troponin I, a cardiac marker used in clinical settings.

The AgPlus Troponin I assay is currently showing a dynamic range of .1ng/ml - 50ng/ml with CVs <20% in a non-optimized format with assay run times of 10 minutes.

In addition, AgPlus tests for cortisol and testosterone are currently in development, which will be of value in sports science applications for developing more tailored training plans for athletes and to help reduce chances of Over Training Syndrome.

The technology has been developed so that it can be applied to new and established chemistries and the platform software is easily integrated into existing information management systems.

AgPlus Diagnostics foresee further potential for this technology in human (clinical and non-clinical) and veterinary diagnostics, as well as in environmental and military applications.

“The first working AgPlus technology system prototype is an important milestone for AgPlus Diagnostics, demonstrating the successful coming together of this novel diagnostic assay and its unique analytical platform to achieve a fully functional, portable system that can deliver accuracy and sensitivity that’s on a par with laboratory analyzers,” comments Chief Executive Officer, Keith Page.

AgPlus Diagnostics is seeking to develop partnerships and licensing agreements with collaborators in a variety of applications and business sectors.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!